A phase II multicenter, randomized, open - label trial of T - VEC [28] in patients with resectable stage IIIB, IIIC, or IV M1a melanoma testing that hypothesis is in the enrollment phase. (cancernetwork.com)
These agents may also have a future role in neoadjuvant treatment for resectable metastatic melanoma. (cancernetwork.com)
Would it be justifiable to consider T - VEC, PV - 10, or CVA21 as an upfront strategy in patients with surgically resectable disease before surgery, with the intent of making the tumor our ally? (cancernetwork.com)